As of Jul 31
| +0.24 / +5.65%|
The 1 analysts offering 12-month price forecasts for Ocata Therapeutics Inc have a median target of 16.00, with a high estimate of 16.00 and a low estimate of 16.00. The median estimate represents a +256.35% increase from the last price of 4.49.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.